Making best practice, everyday practice

Login Register

COVID-19 and Thrombosis

Emerging COVID-19 data indicates a significant role of thrombosis in morbidity/mortality of patients with ARDS, with evidence of clotting system activation; expert advice on the value and safety of anticoagulation favours LMWH/NOAC therapy

Read below to complete the CPD questions


 


Staying ahead of the curve

COVID-19 and Thrombosis

What you will learn:
As the coronavirus pandemic progresses, the critically important role of blood clotting has been recognised in publications from clinicians and scientists worldwide.
 
 
 
This programme:

  • Explains how the response to the infection can trigger a cytokine storm affecting coagulation in seriously ill patients
  • Emphasises the serious implications of these changes on the prognosis of COVID-19 patients
  • Reviews the need for thromboprophylaxis in patients during and after their hospital stay

Presenter
Dr Tony Dalby
Specialist Cardiologist
Life Fourways Hospital
Johannesburg, South Africa
 


 
WATCH THE ACCREDITED VIDEO AND READ THE SUMMARY REPORT
 
Q&A FOR OFFLINE SUBMISSION »
Useful Resources »
 
 
STAY AHEAD OF THE CURVE

 

Submission of questions are now closed

 

 

 
 
This report was made possible by an unrestricted educational grant from Bayer. The content of the report is independent of the sponsor.
 

Do you like this? If you want to share it:

Do you like this? Share with a colleague

[DISPLAY_ULTIMATE_SOCIAL_ICONS]